EN
HI
Summary
As of 25 Aug, 2026, Aarti Drugs stock price is ₹422.2. During the trading session, the stock has moved between an intraday low of ₹415.80 and an intraday high of ₹426.45. Over the last 52 weeks, Aarti Drugs has traded between ₹318.95 and ₹534.55.
The stock has recorded a trading volume of 1,19,365 shares, with a market capitalization of ₹91270000. Its Average Traded Price (ATP) is ₹421.09, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 28 @ ₹422.20.
Aarti Drugs has an upper circuit limit of ₹505.25 and a lower circuit limit of ₹336.85. The total value traded stands at ₹5.03 CR, and the delivery percentage for the day is 42.37%.
The stock is currently traded with a market lot size of 1. Aarti Drugs also offers a dividend yield of 0.48%.
Aarti Drugs share price chart
Aarti Drugs Share Key Metrics
Volume
1.19 L
Market Cap
3853.42 CR
LTQ@LTP
28@422.20
ATP
421.09
Var Margin
17.15 %
Circuit Range
336.85-505.25
Delivery %
42.37 %
Value
5.03 CR
ASM/GSM
No
Market Lot
1
Aarti Drugs Fundamentals
P/E Ratio
20.07
P/B Ratio
2.4
Div. Yield
0.48
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Aarti Drugs Resistance and Support
Pivot 422.75
Resistance
First Resistance
428.1
Second Resistance
435.15
Third Resistance
440.5
Support
First Support
415.7
Second Support
410.35
Third Support
403.3
Aarti Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 423 | 422.2 | 0.28% | 426.45 | 415.8 |
| Mon Aug 24 2026 | 420.7 | 421.04 | 0.87% | 429.79 | 417.39 |
| Fri Aug 21 2026 | 413.45 | 417.39 | 0.64% | 420 | 410.1 |
Aarti Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-15 | Audited Results |
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
| 2025-05-06 | Audited Results |
| 2025-01-29 | Quarterly Results & Interim Dividend |
| 2024-10-24 | Quarterly Results |
| 2024-08-26 | Buy Back of Shares |
| 2024-07-26 | Quarterly Results |
Aarti Drugs News
Aarti Drugs Ltd - 524348 - Board Meeting Intimation for ''Aarti Drugs Limited - Performance Stock Option Plan 2026',
Aarti Drugs board is scheduled to meet on August 27, 2026. The primary agenda is to consider and approve the 'Aarti Drugs Limited – Performance Stock Option Plan 2026' for its employees.
Aug 24 2026 21:48:44
Aarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Aarti Drugs announced that the Supreme Court of India dismissed the Special Leave Petition filed by the GST Department. This ruling upholds the High Court's order, which had set aside a Rs.230.70 crore GST demand and penalty against the company, eliminating a significant potential liability.
Aug 10 2026 21:34:31
Read More
Aarti Drugs Management
| Name | Position |
|---|---|
| Rushikesh Deole | Company Secretary & Compliance Officer |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Drugs Similar Stocks
Supriya Lifescience Ltd.
791.65
-5.50 (0.69%)
Artemis Medicare Services Ltd.
323.70
-5.20 (1.58%)
IOL Chemicals And Pharmaceuticals Ltd.
172.37
3.29 (1.95%)
RPG Life Sciences Ltd.
2584.50
-38.90 (1.48%)
Gufic Biosciences Ltd.
413.65
-4.35 (1.04%)
Kwality Pharmaceuticals Ltd.
3373.10
-79.10 (2.29%)
Indraprastha Medical Corporation Ltd.
372.95
1.05 (0.28%)
Unichem Laboratories Ltd.
526.05
16.25 (3.19%)
Advanced Enzyme Technologies Ltd.
299.75
-2.60 (0.86%)
SMS Pharmaceuticals Ltd.
356.75
2.65 (0.75%)
Aarti Drugs FAQs
The Buying Price of Aarti Drugs share is 422.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 20.07. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Drugs shares is 2.4. Useful to assess the stock's value relative to its book value.
To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Drugs is 3853.42 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Drugs share price is 534.55 & 318.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIDRUGS
Or Download Choice FinX App
Invest in AARTIDRUGS
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade